You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API remimazolam besylate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing remimazolam besylate

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Acacia Pharma Ltd BYFAVO remimazolam besylate 71390-011 DEXTRAN 40 2027-07-10
Acacia Pharma Ltd BYFAVO remimazolam besylate 71390-011 HYDROCHLORIC ACID 2027-07-10
Acacia Pharma Ltd BYFAVO remimazolam besylate 71390-011 LACTOSE MONOHYDRATE 2027-07-10
Acacia Pharma Ltd BYFAVO remimazolam besylate 71390-011 SODIUM HYDROXIDE 2027-07-10
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Detailed excipient profiles for remimazolam besylate

Excipient focus: DEXTRAN 40

Excipient focus: HYDROCHLORIC ACID

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: SODIUM HYDROXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.